Kairos Pharma Enters Agreement With Precheck Health Services to Develop Biomarkers to Identify Patients Responsive to Env105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
凱魯斯製藥與Precheck健康服務達成協議，開發生物標誌物，以識別對Env105響應良好的患者，針對前列腺癌和肺癌患者的癌症藥物抵抗